Table 3.

Prevalence and risk factors for 30-day all-cause mortality in patients with PE

Risk factor	30-day all-cause mortality (n=28, 19.9%)	Univariatea	Multivariateb
		P-value	P-value	95% CI
Age (y)	69.2±12.6	0.638	0.728	0.182–9.966
<50	2 (7.1)
51–69	9 (32.1)
≥70	17 (60.7)
Male	14 (50.0)	0.644	0.832	0.357–3.598
Location of PE		0.183	0.172	0.698–7.422
Main & lobar arteries	14 (50.0)
Segmental & subsegmental arteries	14 (50.0)
DVT	14 (50.0)	0.584	0.873	0.351–3.425
Immobilization ≥3 days	12 (42.9)	0.961	0.467	0.444–5.866
Active malignancy and/or chemotherapy	18 (64.3)	0.001	0.001	5.047–61.320
Comorbidities
HTN	14 (50.0)	0.421	0.408	0.175–2.033
DM	9 (32.1)	0.905	0.747	0.229–2.879
CAD	2 (7.1)	1.000	0.823	0.070–8.298
Congestive heart failure	3 (10.7)	0.705	0.654	0.223–10.925
Cerebrovascular disease	5 (17.9)	0.621	0.362	0.103–2.287
Dementia	1 (3.6)	0.687	0.363	0.013–4.863
Smoking	2 (7.1)	1.000	0.740	0.214–8.730
HR >100/min	11 (39.3)	0.702	0.788	0.338–4.188
SpO2 <90 mmHg	7 (25.0)	0.596	0.127	0.066–1.403
Anticoagulation treatment	22 (78.6)	0.169	0.214	0.080–1.762
Hypotension or shock	9 (32.1)	0.007	0.005	2.117–69.706
Need for inotropics	4 (14.3)	0.229	0.651	0.210–12.164

Values are presented as mean±standard deviation or number (%).

PE, pulmonary embolism; CI, confidence interval; DVT, deep venous thrombosis; HTN, hypertension; DM, diabetes mellitus; CAD, coronary artery disease; HR, heart rate; SpO₂, peripheral oxygen saturation.

^aChi-square test or Fisher’s exact test,

^blogistic regression model.